COVID-19InnovationNews

Bengaluru scientist develops virus attenuation device Shycocan

Shycocan works by neutralising its positive charge and disabling the ability of the coronavirus particles to attach itself to a host cell 

A one-of-its-kind virus attenuation device developed by Bengaluru scientist and inventor Dr Rajah Vijay Kumar is helping curb the spread of coronavirus in indoor spaces.

THIS CAN BE YOUR ADVERTISEMENT

Manufactured by Bengaluru-based Shycocan Corporation, the cylindrical device is called Shycocan, short for Scalene Hypercharge Corona Canon. It has found to be effective in securing indoor spaces from the spread of not only the Coronavirus family which cause diseases like pneumonia, ARDS, SARS, MERS, COVID-19 and other coronavirus induced diseases, but also the influenza family of viruses which trigger annual seasonal flu and serious epidemics such as swine flu and bird flu. Shycocan also works on all current and future variants and mutants of these viruses, protecting people’s health and saving millions of hours of lost productivity. 

Shycocan curbs the spread of coronavirus and influenza viruses by disrupting the process by which they attack humans and animals. The human cell membrane has a negative membrane potential while Coronavirus is a positive-charge virus, whose S-Protein attaches to the human cell and uses its cellular mechanism like a photocopy machine to duplicate itself. Shycocan works by neutralising its positive charge and disabling the ability of the coronavirus particles to attach itself to a host cell. 

Dr Kumar, Global Chairman of Organisation De Scalene, developed the specialised device made of a super-alloy after a decade of research which produces photons of high intensity when excited. Upon striking solid surfaces like particles in the air and tables, chairs, walls, etc. in any space, these emit electrons. The electrons get attached to the positive protein on the shell of the coronavirus and influenza families of viruses, neutralising its positive charge and preventing it from infecting other people. In the presence of Shycocan, anyone touching a previously infected surface will not contract the virus as it would have been attenuated. The device provides far greater protection. The super-alloy generating photons do not deteriorate, hence Shycocan has a long lifespan and requires minimal servicing and no consumables. 

Dr Kumar said, “Coronavirus-type outbreaks are occurring with faster intermittent frequencies. The coronavirus family has got more infectious and deadly with successive mutations in the last 17 years, underscoring the importance of a device like Shycocan. The biggest challenge of this virus is its infectivity or virulence. Breaking the chain of infectivity requires focused work on indoor environments because they carry the highest risk of transmission.” 

Alok Sharma, CEO, Shycocan Corporation said, “Shycocan has been proven to disable the coronavirus and influenza virus families in indoor spaces with 99.994 per cent efficacy, as per various virology reports from accredited laboratories worldwide. There is no adverse impact on humans. The device does not affect any other bacteria or fungi, thus maintaining a balance of microbes in the environment. The Shycocan device is already in use in India, the US and many countries in Europe, Asia Pacific, Australia, New Zealand, the Middle East and Africa.”

Shycocan is a well-designed device that is effective and safe and has been thoroughly tested. It neither uses nor emits radiation, chemicals, ozone or any material that harms humans or the environment. A single device when mounted has an effective coverage area of 1,000 sq ft (or 10,000 cubic feet). Multiple devices can be installed to cover a larger indoor space. Shycocan has widespread usage across market segments like hospitals, clinics, schools, higher education institutions, banking sector, manufacturing and retail outlets, hospitality sector, government offices, real estate corporations and businesses. 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Leave a Reply

Back to top button
Close
Close